These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 395952)

  • 1. Inhibition of collagen-induced platelet aggregation by antibodies to distinct types of collagens.
    Balleisen L; Nowack H; Gay S; Timpl R
    Biochem J; 1979 Dec; 184(3):683-7. PubMed ID: 395952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct roles of GPVI and integrin alpha(2)beta(1) in platelet shape change and aggregation induced by different collagens.
    Jarvis GE; Atkinson BT; Snell DC; Watson SP
    Br J Pharmacol; 2002 Sep; 137(1):107-17. PubMed ID: 12183336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A collagen-like immunodeterminant on the surface of Streptococcus sanguis induces platelet aggregation.
    Erickson PR; Herzberg MC
    J Immunol; 1987 May; 138(10):3360-6. PubMed ID: 2437190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-collagen interaction. Inhibition by a monoclonal antibody raised against collagen receptor.
    Chiang TM; Jin A; Kang AH
    J Immunol; 1987 Aug; 139(3):887-92. PubMed ID: 3598192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of pepsin solubilization on platelet aggregation by types I and III collagens.
    Hill RJ; Baugh R; Harper E
    Thromb Res; 1985 Apr; 38(1):45-59. PubMed ID: 3923648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collagen-platelet interaction. Type V(A-B) collagen induced platelet aggregation.
    Chiang TM; Mainardi CL; Seyer JM; Kang AH
    J Lab Clin Med; 1980 Jan; 95(1):99-107. PubMed ID: 7350245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of thrombospondin in platelet aggregation.
    Leung LL
    J Clin Invest; 1984 Nov; 74(5):1764-72. PubMed ID: 6501568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered expression of the platelet aggregation-associated protein from Streptococcus sanguis after growth in the presence of collagen.
    Erickson PR; Herzberg MC
    Infect Immun; 1995 Mar; 63(3):1084-8. PubMed ID: 7868231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelets deficient in glycoprotein IIIb aggregate normally to collagens type I and III but not to collagen type V.
    Kehrel B; Kronenberg A; Rauterberg J; Niesing-Bresch D; Niehues U; Kardoeus J; Schwippert B; Tschöpe D; van de Loo J; Clemetson KJ
    Blood; 1993 Dec; 82(11):3364-70. PubMed ID: 7694682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteonectin is an alpha-granule component involved with thrombospondin in platelet aggregation.
    Clezardin P; Malaval L; Morel MC; Guichard J; Lecompte T; Trzeciak MC; Dechavanne M; Breton-Gorius J; Delmas PD; Kaplan C
    J Bone Miner Res; 1991 Oct; 6(10):1059-70. PubMed ID: 1796754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-collagen interaction. The influence of native and modified collagen (Type I) on the aggregation of human platelets.
    Balleisen L; Marx R; Kühn K
    Haemostasis; 1976; 5(3):155-64. PubMed ID: 1002002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti GPVI human antibodies neutralizing collagen-induced platelet aggregation isolated from a combinatorial phage display library.
    Qian MD; Villeval JL; Xiong X; Jandrot-Perrus M; Nagashima K; Tonra J; McDonald K; Goodearl A; Gill D
    Hum Antibodies; 2002; 11(3):97-105. PubMed ID: 12454370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The size of collagen fibrils that stimulate platelet aggregation in human plasma.
    Kronick P; Jimenez SA
    Biochem J; 1980 Jan; 186(1):5-12. PubMed ID: 7370021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the epitope for a monoclonal antibody that blocks platelet aggregation induced by type III collagen.
    Glattauer V; Werkmeister JA; Kirkpatrick A; Ramshaw JA
    Biochem J; 1997 Apr; 323 ( Pt 1)(Pt 1):45-9. PubMed ID: 9173900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of certain antiplatelet drugs to affect myointimal thickening following arterial endothelial injury in the rat.
    Clowes AW; Karnovsky MJ
    Lab Invest; 1977 Apr; 36(4):452-64. PubMed ID: 846193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-reactivity of isolated constituents of the blood vessel wall.
    Barnes MJ; MacIntyre DE
    Haemostasis; 1979; 8(3-5):158-70. PubMed ID: 389755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Fab fragment of a novel anti-GPVI monoclonal antibody, OM4, reduces in vivo thrombosis without bleeding risk in rats.
    Li H; Lockyer S; Concepcion A; Gong X; Takizawa H; Guertin M; Matsumoto Y; Kambayashi J; Tandon NN; Liu Y
    Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1199-205. PubMed ID: 17322098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Collagen nonapeptide, a trap for platelets].
    Legrand YJ; Karniguian A; Fauvel F
    Presse Med; 1983 Oct; 12(37):2327-30. PubMed ID: 6226983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Qualitative description of factors involved in the retraction and lysis of dilute whole blood clots and in the aggregation and retraction of platelets.
    Taylor FB; Müller-Eberhard HJ
    J Clin Invest; 1970 Nov; 49(11):2068-85. PubMed ID: 4248913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A synthetic peptide derived from the sequence of a type I collagen receptor inhibits type I collagen-mediated platelet aggregation.
    Chiang TM; Kang AH
    J Clin Invest; 1997 Oct; 100(8):2079-84. PubMed ID: 9329973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.